1-10 of 10
Nilanjan Ghosh
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Magrolimab plus rituximab in relapsed/refractory indolent non-Hodgkin lymphoma: 3-year follow-up of a phase 1/2 trial

Clinical Trials & Observations
Amitkumar Mehta, Leslie Popplewell, Graham P. Collins, Sonali M. Smith, Ian W. Flinn, Nancy L. Bartlett, Nilanjan Ghosh, Gal Hacohen-Kleiman, Yanan Huo, Linda Su-Feher, Camille Renard, Ranjana Advani, Mark Roschewski
Journal: Blood Advances
Blood Adv (2024) 8 (22): 5855–5863.
https://doi.org/10.1182/bloodadvances.2024013277
Published: 2024
Includes: Supplemental data
Journal Articles

Magrolimab plus rituximab with or without chemotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma

Clinical Trials & Observations
Joseph E. Maakaron, Adam Asch, Leslie Popplewell, Graham P. Collins, Ian W. Flinn, Nilanjan Ghosh, Colm Keane, Matthew Ku, Amitkumar Mehta, Mark Roschewski, Gal Hacohen-Kleiman, Yanan Huo, Yi Zhang, Camille Renard, Sonali M. Smith, Ranjana Advani
Journal: Blood Advances
Blood Adv (2024) 8 (22): 5864–5874.
https://doi.org/10.1182/bloodadvances.2024013338
Published: 2024
Includes: Supplemental data
Journal Articles

Real-world prognostic testing and treatment patterns in CLL/SLL: results from 1462 patients in the informCLL registry

Clinical Trials & Observations
Anthony R. Mato, Nilanjan Ghosh, Jeff P. Sharman, Danielle Brander, Meghan Gutierrez, Qing Huang, Linda H. Wu, Alex Young, Sandhya Upasani, Maoko Naganuma, Jacqueline C. Barrientos
Journal: Blood Advances
Blood Adv (2023) 7 (17): 4760–4764.
https://doi.org/10.1182/bloodadvances.2022008068
Published: 2023
Includes: Supplemental data
Journal Articles

Impact of diagnosis to treatment interval in patients with newly diagnosed mantle cell lymphoma

Clinical Trials & Observations
Narendranath Epperla, Jeffrey Switchenko, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Max J. Gordon, Alexey V. Danilov, Natalie S. Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Yazeed Sawalha, Brian T. Hill, Nilanjan Ghosh, Steven I. Park, David A. Bond, Mehdi Hamadani, Timothy S. Fenske, Peter Martin, Mary-Kate Malecek, Brad S. Kahl, Christopher R. Flowers, Brian K. Link, Lawrence D. Kaplan, David J. Inwards, Andrew L. Feldman, Eric D. Hsi, Kami Maddocks, Kristie A. Blum, Nancy L. Bartlett, James R. Cerhan, John P. Leonard, Thomas M. Habermann, Matthew J. Maurer, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2023) 7 (11): 2287–2296.
https://doi.org/10.1182/bloodadvances.2022009225
Published: 2023
Includes: Supplemental data
Journal Articles

Postibrutinib relapse outcomes for patients with marginal zone lymphoma

Narendranath Epperla, Qiuhong Zhao, Sayan Mullick Chowdhury, Lauren Shea, Tamara K. Moyo, Nishitha Reddy, Julia Sheets, David M. Weiner, Praveen Ramakrishnan Geethakumari, Malathi Kandarpa, Ximena Jordan Bruno, Colin Thomas, Michael C. Churnetski, Andrew Hsu, Luke Zurbriggen, Xiao-wei Cherie Tan, Kathryn Lindsey, Joseph Maakaron, Paolo F. Caimi, Pallawi Torka, Celeste Bello, Sabarish Ayyappan, Timothy S. Oh, Reem Karmali, Seo-Hyun Kim, Anna Kress, Shalin Kothari, Yazeed Sawalha, Beth Christian, Kevin A. David, Irl Brian Greenwell, Murali Janakiram, Vaishalee P. Kenkre, Adam J. Olszewski, Jonathon B. Cohen, Neil Palmisiano, Elvira Umyarova, Ryan A. Wilcox, Farrukh T. Awan, Juan Pablo Alderuccio, Stefan K. Barta, Natalie S. Grover, Nilanjan Ghosh, Nancy L. Bartlett, Alex F. Herrera, Geoffrey Shouse
Journal: Blood Advances
Blood Adv (2023) 7 (1): 88–91.
https://doi.org/10.1182/bloodadvances.2022008634
Published: 2023
Includes: Supplemental data
Journal Articles

Integrated safety analysis of umbralisib, a dual PI3Kδ/CK1ε inhibitor, in relapsed/refractory lymphoid malignancies

Clinical Trials & Observations
Matthew S. Davids, Owen A. O’Connor, Wojciech Jurczak, Felipe Samaniego, Timothy S. Fenske, Pier Luigi Zinzani, Manish R. Patel, Nilanjan Ghosh, Bruce D. Cheson, Enrico Derenzini, Danielle M. Brander, James A. Reeves, Wanda Knopińska-Posłuszny, John N. Allan, Tycel Phillips, Paolo F. Caimi, Ewa Lech-Maranda, John M. Burke, Richy Agajanian, Ruth Pettengell, Lori A. Leslie, Chan Y. Cheah, Gustavo Fonseca, James Essell, Julio C. Chavez, John M. Pagel, Jeff P. Sharman, Yanzhi Hsu, Hari P. Miskin, Peter Sportelli, Michael S. Weiss, Ian W. Flinn
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5332–5343.
https://doi.org/10.1182/bloodadvances.2021005132
Published: 2021
Includes: Supplemental data
Journal Articles

Early relapse identifies MCL patients with inferior survival after intensive or less intensive frontline therapy

Clinical Trials & Observations
David A. Bond, Jeffrey M. Switchenko, Diego Villa, Kami Maddocks, Michael Churnetski, Alina S. Gerrie, Subir Goyal, Krithika Shanmugasundaram, Oscar Calzada, Bhaskar Kolla, Veronika Bachanova, James N. Gerson, Stefan K. Barta, Brian T. Hill, Yazeed Sawalha, Peter Martin, Edward Maldonado, Max Gordon, Alexey V. Danilov, Natalie S. Grover, Stephanie Mathews, Madelyn Burkart, Reem Karmali, Nilanjan Ghosh, Steven I. Park, Narendranath Epperla, Talha Badar, Jin Guo, Mehdi Hamadani, Timothy S. Fenske, Mary-Kate Malecek, Brad S. Kahl, Christopher R. Flowers, Kristie A. Blum, Jonathon B. Cohen
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5179–5189.
https://doi.org/10.1182/bloodadvances.2021004765
Published: 2021
Includes: Supplemental data
Journal Articles

Phase 1b study of the BET protein inhibitor RO6870810 with venetoclax and rituximab in patients with diffuse large B-cell lymphoma

Clinical Trials & Observations
Michael Dickinson, Javier Briones, Alex F. Herrera, Eva González-Barca, Nilanjan Ghosh, Raul Cordoba, Sarah C. Rutherford, Eirini Bournazou, Emily Labriola-Tompkins, Izolda Franjkovic, Evelyne Chesne, Jurriaan Brouwer-Visser, Katharina Lechner, Barbara Brennan, Eveline Nüesch, Mark DeMario, Dominik Rüttinger, Martin Kornacker, Martin Hutchings
Journal: Blood Advances
Blood Adv (2021) 5 (22): 4762–4770.
https://doi.org/10.1182/bloodadvances.2021004619
Published: 2021
Includes: Supplemental data
Journal Articles

Long-term remission in multiply relapsed enteropathy-associated T-cell lymphoma following CD30 CAR T-cell therapy

Clinical Trials & Observations
Timothy J. Voorhees, Nilanjan Ghosh, Natalie Grover, Jared Block, Catherine Cheng, Kaitlin Morrison, Anastasia Ivanova, Gianpietro Dotti, Jonathan Serody, Barbara Savoldo, Anne W. Beaven
Journal: Blood Advances
Blood Adv (2020) 4 (23): 5925–5928.
https://doi.org/10.1182/bloodadvances.2020003218
Published: 2020
Journal Articles

ABVD followed by BV consolidation in risk-stratified patients with limited-stage Hodgkin lymphoma

Clinical Trials & Observations
Steven I. Park, Thomas C. Shea, Oludamilola Olajide, Nishitha M. Reddy, Lihua E. Budde, Nilanjan Ghosh, Allison M. Deal, Jeanne F. Noe, Stephen M. Ansell
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2548–2555.
https://doi.org/10.1182/bloodadvances.2020001871
Published: 2020
Includes: Supplemental data